Blue Bell Private Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Blue Bell Private Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11	Closed	-$838	–	695
2023 Q1	$838	Hold	11	–	–	﹤0.01%	624
2022 Q4	$913	Hold	11	–	–	﹤0.01%	641
2022 Q3	$1K	Sell	11 -40	-78%	-$3.37K	﹤0.01%	721
2022 Q2	$4K	Hold	51	–	–	﹤0.01%	572
2022 Q1	$5K	Sell	51 -157	-75%	-$14.5K	﹤0.01%	571
2021 Q4	$23K	Buy	+208	New	+$25.1K	0.01%	293

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

Blue Bell Private Wealth Management's XBI Position: Q2 2023 in Review

Blue Bell Private Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2023, closing a stake of 11 shares — an estimated $838 sold.

Blue Bell Private Wealth Management first reported a position in XBI in Q4 2021 and held it in 6 quarters. The position peaked at $23K in Q4 2021. 712 funds tracked by Wall St. Rank hold XBI as of Q2 2023.

Blue Bell Private Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2023 after selling out during the quarter.
Blue Bell Private Wealth Management sold 11 State Street SPDR S&P Biotech ETF shares in Q2 2023, an estimated $838.
Blue Bell Private Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 6 quarters.
Blue Bell Private Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $23K in Q4 2021.
712 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.

Based on Blue Bell Private Wealth Management's 13F filing for Q2 2023, filed 8 Aug 2023.